SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 265.62 |
| Enterprise Value ($M) | 173.26 |
| Book Value ($M) | 213.96 |
| Book Value / Share | 4.02 |
| Price / Book | 1.24 |
| NCAV ($M) | -67.46 |
| NCAV / Share | -1.27 |
| Price / NCAV | -3.94 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.01 |
| Return on Assets (ROA) | -0.01 |
| Return on Equity (ROE) | -0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.80 |
| Current Ratio | 4.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 198.58 |
| Assets | 480.00 |
| Liabilities | 266.04 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 37.86 |
| Operating Income | -105.54 |
| Net Income | -57.25 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -85.00 |
| Cash from Investing | 80.76 |
| Cash from Financing | 0.42 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.38 | -29.26 | |
| 13G | Glazer Capital, Llc | 5.25 | ||
| 13G | Beryl Capital Management LLC | 8.10 | ||
| 13G/A | Kynam Capital Management, LP | 0.00 | -100.00 | |
| 13G/A | Morgan Stanley | 5.50 | -40.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,539 | 253,879 | 9.27 | |
| 95,836 | 304,388 | 31.48 | |
| 65,815 | 216,175 | 30.45 | |
| 119,660 | 1,087,021 | 11.01 | |
| 197,065 | 1,349,080 | 14.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TNYA – Tenaya Therapeutics, Inc. | TRML – Tourmaline Bio, Inc. |
| TSHA – Taysha Gene Therapies, Inc. | TWST – Twist Bioscience Corporation |
| TXMD – TherapeuticsMD, Inc. |
Financial data and stock pages provided by
Fintel.io